# NBT Bancorp Inc: financial statements, quarterly

NBTB · Nasdaq · CIK 790359 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nbtb.md) · [Financials](/companies/nbtb/financials.md) · [Filings](/companies/nbtb/filings.md) · [Insiders](/companies/nbtb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nbtb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [42.2](/filings/0001140361-23-052435.md) | [51.7 d](/filings/0001140361-24-010464.md) | [51.8](/filings/0001140361-24-025185.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.1](/filings/0001140361-24-045834.md) | [9.3 d](/filings/0001140361-26-007179.md) | [9.4](/filings/0001140361-25-018153.md) | [9.2](/filings/0001140361-25-029850.md) | [10.7](/filings/0001140361-25-041148.md) | [9.5 d](/filings/0001140361-26-007179.md) | [10.5](/filings/0001140361-26-020019.md) | [8.2](/filings/0001140361-26-031820.md) | [17.4](/filings/0001140361-25-041148.md) | [14.2 d](/filings/0001140361-26-007179.md) | [15.5](/filings/0001140361-26-020019.md) | [16.1](/filings/0001140361-26-031820.md) |
| Net income | $m | [24.6](/filings/0001140361-24-045834.md) | [30.4 d](/filings/0001140361-26-007179.md) | [33.8](/filings/0001140361-25-018153.md) | [32.7](/filings/0001140361-25-029850.md) | [38.1](/filings/0001140361-25-041148.md) | [36.0 d](/filings/0001140361-26-007179.md) | [36.7](/filings/0001140361-26-020019.md) | [22.5](/filings/0001140361-26-031820.md) | [54.5](/filings/0001140361-25-041148.md) | [55.5 d](/filings/0001140361-26-007179.md) | [51.1](/filings/0001140361-26-020019.md) | [53.0](/filings/0001140361-26-031820.md) |
| Diluted EPS | $ per share | [0.54](/filings/0001140361-24-045834.md) | not reported | [0.71](/filings/0001140361-25-018153.md) | [0.69](/filings/0001140361-25-029850.md) | [0.80](/filings/0001140361-25-041148.md) | not reported | [0.77](/filings/0001140361-26-020019.md) | [0.44](/filings/0001140361-26-031820.md) | [1.03](/filings/0001140361-25-041148.md) | not reported | [0.98](/filings/0001140361-26-020019.md) | [1.02](/filings/0001140361-26-031820.md) |
| Basic EPS | $ per share | [0.54](/filings/0001140361-24-045834.md) | not reported | [0.72](/filings/0001140361-25-018153.md) | [0.69](/filings/0001140361-25-029850.md) | [0.81](/filings/0001140361-25-041148.md) | not reported | [0.78](/filings/0001140361-26-020019.md) | [0.45](/filings/0001140361-26-031820.md) | [1.04](/filings/0001140361-25-041148.md) | not reported | [0.98](/filings/0001140361-26-020019.md) | [1.02](/filings/0001140361-26-031820.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [13.8](/filings/0001140361-23-052435.md) | [13.3](/filings/0001140361-26-007179.md) | [13.4](/filings/0001140361-25-018153.md) | [13.5](/filings/0001140361-25-029850.md) | [13.8](/filings/0001140361-25-041148.md) | [13.8](/filings/0001140361-26-007179.md) | [13.9](/filings/0001140361-26-020019.md) | [16.0](/filings/0001140361-26-031820.md) | [16.1](/filings/0001140361-25-041148.md) | [16.0](/filings/0001140361-26-031820.md) | [16.2](/filings/0001140361-26-020019.md) | [16.2](/filings/0001140361-26-031820.md) |
| Total liabilities | $bn | [12.5](/filings/0001140361-23-052435.md) | [11.9](/filings/0001140361-25-006528.md) | [12.0](/filings/0001140361-24-025185.md) | [12.0](/filings/0001140361-24-036613.md) | [12.3](/filings/0001140361-24-045834.md) | [12.3](/filings/0001140361-26-007179.md) | [12.3](/filings/0001140361-25-018153.md) | [14.2](/filings/0001140361-25-029850.md) | [14.3](/filings/0001140361-25-041148.md) | [14.1](/filings/0001140361-26-031820.md) | [14.3](/filings/0001140361-26-020019.md) | [14.3](/filings/0001140361-26-031820.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.5](/filings/0001140361-23-052435.md) | [0.4](/filings/0001140361-25-006528.md) | [0.3](/filings/0001140361-24-025185.md) | [0.2](/filings/0001140361-24-036613.md) | [0.2](/filings/0001140361-24-045834.md) | [0.2](/filings/0001140361-26-007179.md) | [0.1](/filings/0001140361-25-018153.md) | [0.1](/filings/0001140361-25-029850.md) | [0.1](/filings/0001140361-25-041148.md) | [0.1](/filings/0001140361-26-031820.md) | [0.1](/filings/0001140361-26-020019.md) | [0.3](/filings/0001140361-26-031820.md) |
| Shareholders' equity | $bn | [1.4](/filings/0001140361-24-045834.md) | [1.4](/filings/0001140361-26-007179.md) | [1.4](/filings/0001140361-25-029850.md) | [1.5](/filings/0001140361-25-041148.md) | [1.5](/filings/0001140361-25-041148.md) | [1.5](/filings/0001140361-26-031820.md) | [1.6](/filings/0001140361-26-031820.md) | [1.8](/filings/0001140361-26-031820.md) | [1.9](/filings/0001140361-25-041148.md) | [1.9](/filings/0001140361-26-031820.md) | [1.9](/filings/0001140361-26-031820.md) | [1.9](/filings/0001140361-26-031820.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [54.6 d](/filings/0001140361-24-045834.md) | [35.7 d](/filings/0001140361-26-007179.md) | [36.7](/filings/0001140361-25-018153.md) | [50.5 d](/filings/0001140361-25-029850.md) | [52.1 d](/filings/0001140361-25-041148.md) | [49.2 d](/filings/0001140361-26-007179.md) | [42.0](/filings/0001140361-26-020019.md) | [46.5 d](/filings/0001140361-26-031820.md) | [80.6 d](/filings/0001140361-25-041148.md) | [66.1 d](/filings/0001140361-26-007179.md) | [53.0](/filings/0001140361-26-020019.md) | [61.9 d](/filings/0001140361-26-031820.md) |
| Capital expenditure | $m | [3.5 d](/filings/0001140361-24-045834.md) | [2.9 d](/filings/0001140361-26-007179.md) | [2.4](/filings/0001140361-25-018153.md) | [1.4 d](/filings/0001140361-25-029850.md) | [4.3 d](/filings/0001140361-25-041148.md) | [3.6 d](/filings/0001140361-26-007179.md) | [3.7](/filings/0001140361-26-020019.md) | [2.3 d](/filings/0001140361-26-031820.md) | [6.2 d](/filings/0001140361-25-041148.md) | [4.0 d](/filings/0001140361-26-007179.md) | [4.4](/filings/0001140361-26-020019.md) | [1.4 d](/filings/0001140361-26-031820.md) |
| Dividends paid | $m | [15.1 d](/filings/0001140361-24-045834.md) | [15.1 d](/filings/0001140361-26-007179.md) | [15.1](/filings/0001140361-25-018153.md) | [15.1 d](/filings/0001140361-25-029850.md) | [16.0 d](/filings/0001140361-25-041148.md) | [16.0 d](/filings/0001140361-26-007179.md) | [16.1](/filings/0001140361-26-020019.md) | [17.8 d](/filings/0001140361-26-031820.md) | [19.4 d](/filings/0001140361-25-041148.md) | [19.3 d](/filings/0001140361-26-007179.md) | [19.2](/filings/0001140361-26-020019.md) | [19.2 d](/filings/0001140361-26-031820.md) |
| Share repurchases | $m | [2.2 d](/filings/0001140361-24-045834.md) | [0.0 d](/filings/0001140361-26-007179.md) | [0.1](/filings/0001140361-25-018153.md) | [0.2 d](/filings/0001140361-25-029850.md) | [0.0 d](/filings/0001140361-25-041148.md) | [0.0 d](/filings/0001140361-26-007179.md) | [0.0](/filings/0001140361-26-020019.md) | [0.0 d](/filings/0001140361-26-031820.md) | [0.0 d](/filings/0001140361-25-041148.md) | [10.2 d](/filings/0001140361-26-007179.md) | [11.0](/filings/0001140361-26-020019.md) | [3.0 d](/filings/0001140361-26-031820.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [42.8](/filings/0001140361-23-052435.md) | [42.9](/filings/0001140361-24-025185.md) | [42.9](/filings/0001140361-24-036613.md) | [45.2](/filings/0001140361-24-045834.md) | [47.1](/filings/0001140361-25-018153.md) | [47.2](/filings/0001140361-25-029850.md) | [47.2](/filings/0001140361-25-041148.md) | [47.2](/filings/0001140361-26-020019.md) | [50.6](/filings/0001140361-26-031820.md) | [52.4](/filings/0001140361-25-041148.md) | [52.1](/filings/0001140361-26-020019.md) | [52.0](/filings/0001140361-26-031820.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,960,061 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001140361-26-031820.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.